Immunocore Hldgs Analyst Ratings
Immunocore Hldgs Analyst Ratings
Buy Rating Affirmed: Immunocore's Promising Survival Data and High Disease Control Rate in Advanced Melanoma
Buy Rating on Immunocore Holdings Backed by Promising Phase I/II Study Results and Potential T-cell Profile Benefits
Positive Outlook for Immunocore's KIMMTRAK Bolsters Buy Rating Amidst Advancing Clinical Trials
Immunocore Hldgs Analyst Ratings
Immunocore Hldgs Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Ardelyx (ARDX), Cogent Biosciences (COGT) and Immunocore Holdings (IMCR)
Analysts Offer Insights on Healthcare Companies: Merus (MRUS) and Immunocore Holdings (IMCR)
Immunocore Hldgs Analyst Ratings
Immunocore Holdings (IMCR) Receives a Buy From Barclays
Analysts Offer Insights on Healthcare Companies: Cresco Labs (OtherCRLBF) and Immunocore Holdings (IMCR)
Optimistic Buy Rating for Immunocore Holdings Amid Promising Brenetafusp Study and Strategic Developments
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Immunocore Holdings (IMCR) and Madrigal Pharmaceuticals (MDGL)
Analysts Have Conflicting Sentiments on These Healthcare Companies: OptimizeRx (OPRX), Immunocore Holdings (IMCR) and Acadia Healthcare (ACHC)
Immunocore Hldgs Analyst Ratings
Analysts Have Conflicting Sentiments on These Healthcare Companies: Immunocore Holdings (IMCR), Warby Parker (WRBY) and Ocular Therapeutix (OCUL)
Analysts Offer Insights on Healthcare Companies: Tango Therapeutics (TNGX), Aclaris Therapeutics (ACRS) and Immunocore Holdings (IMCR)
Immunocore Hldgs Analyst Ratings
Buy Rating Affirmed for Immunocore Holdings on Strong KIMMTRAK Sales and Promising Pipeline Growth
No Data